These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33170119)

  • 1. High mortality by nosocomial infections caused by carbapenem-resistant
    Urzedo JE; de Paula Menezes R; Porto JP; Ferreira ML; Gonçalves IR; de Brito CS; Gontijo-Filho PP; Ribas RM
    J Med Microbiol; 2020 Dec; 69(12):1388-1397. PubMed ID: 33170119
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular epidemiological survey of the quinolone- and carbapenem-resistant genotype and its association with the type III secretion system in Pseudomonas aeruginosa.
    Ferreira ML; Dantas RC; Faria ALS; Gonçalves IR; Silveira de Brito C; Queiroz LL; Gontijo-Filho PP; Ribas RM
    J Med Microbiol; 2015 Mar; 64(Pt 3):262-271. PubMed ID: 25596115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
    Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
    Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Resistance and Type III Secretion System Virulotypes of Pseudomonas aeruginosa Isolates from Dogs and Cats in Primary Veterinary Hospitals in Japan: Identification of the International High-Risk Clone Sequence Type 235.
    Hayashi W; Izumi K; Yoshida S; Takizawa S; Sakaguchi K; Iyori K; Minoshima KI; Takano S; Kitagawa M; Nagano Y; Nagano N
    Microbiol Spectr; 2021 Oct; 9(2):e0040821. PubMed ID: 34585944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominance of carbapenem-resistant Pseudomonas aeruginosa isolates carrying blaIMP and blaVIM metallo-β-lactamases in a major hospital in Costa Rica.
    Toval F; Guzmán-Marte A; Madriz V; Somogyi T; Rodríguez C; García F
    J Med Microbiol; 2015 Jan; 64(Pt 1):37-43. PubMed ID: 25355933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
    Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
    J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of carbapenem-resistant Pseudomonas aeruginosa strains isolated from patients with urinary tract infections in Southern Poland.
    Pobiega M; Maciąg J; Chmielarczyk A; Romaniszyn D; Pomorska-Wesolowska M; Ziolkowski G; Heczko PB; Bulanda M; Wojkowska-Mach J
    Diagn Microbiol Infect Dis; 2015 Nov; 83(3):295-7. PubMed ID: 26341705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
    Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
    J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
    Mohanty S; Maurya V; Gaind R; Deb M
    J Infect Dev Ctries; 2013 Nov; 7(11):880-7. PubMed ID: 24240048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the virulence genes and their correlation with carbapenem resistance amongst the Pseudomonas aeruginosa strains isolated from a tertiary hospital in China.
    Wang X; Gao K; Chen C; Zhang C; Zhou C; Song Y; Guo W
    Antonie Van Leeuwenhoek; 2023 Dec; 116(12):1395-1406. PubMed ID: 37847452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
    Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
    Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome.
    Dantas RC; Ferreira ML; Gontijo-Filho PP; Ribas RM
    J Med Microbiol; 2014 Dec; 63(Pt 12):1679-1687. PubMed ID: 25261066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular characterization of carbapenem-resistant and metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from blood cultures from children and teenagers with cancer].
    Fernandes TA; Pereira CA; Petrili AS; Pignatari AC
    Rev Soc Bras Med Trop; 2010; 43(4):372-6. PubMed ID: 20802933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between virulence genotype and fluoroquinolone resistance in carbapenem-resistant Pseudomonas aeruginosa.
    Cho HH; Kwon KC; Kim S; Koo SH
    Ann Lab Med; 2014 Jul; 34(4):286-92. PubMed ID: 24982833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
    Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and microbiological features of infections caused by Pseudomonas aeruginosa in patients hospitalized in intensive care units.
    Matos EC; Matos HJ; Conceição ML; Rodrigues YC; Carneiro IC; Lima KV
    Rev Soc Bras Med Trop; 2016; 49(3):305-11. PubMed ID: 27384827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.